DYNE THERAPEUTICS INC (DYN:NASDAQ)
$14.25 -1.04 (-6.8018%)
Analysed DYNE THERAPEUTICS INC (DYN:NASDAQ) News Sources
Dyne Therapeutics Myotonic Dystrophy Approach Remains Differentiated, RBC Says
09-09-2026
yahoo.com
Top 4 Healthcare Stocks Backed by Raymond James Analysts
08-10-2026
yahoo.com
Dyne Therapeutics to Present Preclinical Data for Multiple Development Candidates for Duchenne Muscular Dystrophy (DMD) at 27th Annual NMSG Scientific Meeting
03-09-2026
yahoo.com
Dyne Therapeutics Shares Fall 31% Premarket With No Catalyst Confirmed
08-09-2026
advfn.com
Wall Street Weighs Impact On DYN Stock Post Novartis’ Phase 3 Failure — RBC Says These Key Differences Could Lead To Better Outcomes
09-09-2026
stocktwits.com
Do Dyne Therapeutics’ (DYN) Expanded DM1 Data Presentations Redefine Its Rare-Disease Investment Narrative?
17-09-2026
yahoo.com
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
17-09-2026
yahoo.com
Dyne Therapeutics Announces Additional One-Year Clinical Data from Phase 1/2 ACHIEVE Trial of Z-Basivarsen (DYNE-101) for Myotonic Dystrophy Type 1 (DM1)
29-09-2026
yahoo.com
Dyne Therapeutics stock rises on positive DM1 trial results
29-09-2026
yahoo.com
Why Dyne Therapeutics (DYN) Is Back In The Spotlight
07-10-2026
yahoo.com
What is the current price of DYNE THERAPEUTICS INC (DYN:NASDAQ)?
The current price of DYNE THERAPEUTICS INC (DYN:NASDAQ) is $14.25.
DYNE THERAPEUTICS INC (DYN:NASDAQ) absolute price change since previous trading day?
The absolute price change of DYNE THERAPEUTICS INC (DYN:NASDAQ) since the previous trading day is $-1.04.
DYNE THERAPEUTICS INC (DYN:NASDAQ) percentage price change since previous trading day?
The percentage price change of DYNE THERAPEUTICS INC (DYN:NASDAQ) since the previous trading day is -6.8018%.
What is the most recent average sentiment score for DYNE THERAPEUTICS INC (DYN:NASDAQ)?
The most recent average sentiment score for DYNE THERAPEUTICS INC (DYN:NASDAQ) is 80 out of 100.
What is the most recent average sentiment for DYNE THERAPEUTICS INC (DYN:NASDAQ)?
The most recent sentiment for DYNE THERAPEUTICS INC (DYN:NASDAQ) is .
SEC-8K** Filing Available For DYNE THERAPEUTICS INC (DYN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.